TUESDAY, Oct. 17, 2023 (HealthDay News) — Women are more likely to develop depression after suffering a traumatic brain injury (TBI), a new study shows. The analysis of nine published studies included nearly 700,000 people and found that the risk for depression among women after a TBI was nearly 50%Continue Reading
THURSDAY, Oct. 12, 2023 (HealthDay News) — After a massive five-year effort, researchers have unveiled an “atlas” that gives an unprecedented look at the intricacies of the human brain. The atlas, which will be available to researchers everywhere, can be seen as similar to the atlases we all know: aContinue Reading
THURSDAY, Oct. 12, 2023 (HealthDay News) — Severe inflammation very early in childhood might hamper the development of key brain cells, perhaps setting the stage for conditions such as autism or schizophrenia, new research suggests. The origins of many neurodevelopment disorders remain mysterious. But the new study of postmortem brainContinue Reading
THURSDAY, Oct. 12, 2023 (HealthDay News) — A new guideline from four leading medical organizations should help doctors determine if someone is brain dead. “Until now, there have been two separate guidelines for determining brain death, one for adults and one for children,” said author Dr. Matthew Kirschen, a criticalContinue Reading
THURSDAY, Oct. 12, 2023 (HealthDay News) — Most folks know that certain antidepressants have to be taken for a few weeks before people start seeing improvement, and now a new study sheds light on that delay. Scientists have discovered this is because of physical changes in the brain that unfoldContinue Reading
WEDNESDAY, Oct. 11, 2023 (HealthDay News) — A medication already approved for excessive daytime sleepiness may help ease attention-deficit/hyperactivity disorder (ADHD) symptoms in adults who aren’t getting relief from available treatments, according to a small pilot study. Solriamfetol is a nonstimulant drug that is approved for sleepiness caused by narcolepsyContinue Reading
TUESDAY, Oct. 10, 2023 (HealthDay News) — For people with tough-to-treat epilepsy, seizures can be both frightening and dangerous, but a new experimental pill may bring significant relief to over one-third of them. Dubbed XEN1101, the new drug reduced the frequency of seizures by more than 50%, or even eliminatedContinue Reading
TUESDAY, Oct. 10, 2023 (HealthDay News) — As many doctors and patients hail the advent of weight-loss drugs like Ozempic and Wegovy as the perfect fix for obesity, some experts are urging caution. The drugs are not well-tolerated by everyone struggling with obesity. For some folks, the weight piles backContinue Reading
MONDAY, Oct. 9, 2023 (HealthDay News) — Researchers have developed an antibody that can reduce Alzheimer’s-like brain damage in lab mice — inspired by the case of one woman with remarkable resistance to the disease. The work, by researchers at Mass General Brigham, Harvard Medical School in Boston, and elsewhere,Continue Reading
FRIDAY, Oct. 6, 2023 (HealthDay News) — Former pro football players with symptoms of depression or anxiety are far more likely to receive an unverifiable diagnosis of chronic traumatic encephalopathy (CTE) than players without those mental health conditions, a new study reports. Players with depression are 9.5 times more likelyContinue Reading